Scarica l'app Stockscreener
2.71
11.73%
-0.36
Dopo l'orario di chiusura:
2.66
-0.05
-1.85%
Heartbeam Inc Borsa (BEAT) Ultime notizie
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - Digital Journal
Will HeartBeam Inc. Equity Warrant stock outperform tech sector in 2025Market Trend Summary & Precise Trade Entry Recommendations - Улправда
Will HeartBeam Inc. stock deliver shareholder value2025 Market WrapUp & Reliable Entry Point Trade Alerts - Улправда
Will HeartBeam Inc. Equity Warrant stock benefit from upcoming earnings reportsJuly 2025 Technicals & Consistent Profit Trade Alerts - Улправда
Analyst Downgrade: How institutional buying supports HeartBeam Inc. Equity Warrant stock2025 Valuation Update & Detailed Earnings Play Alerts - Улправда
Is HeartBeam Inc. Equity Warrant stock a bargain at current levels2025 Retail Activity & Daily Chart Pattern Signal Reports - Улправда
HeartBeam Shares Tumble: Road to Recovery? - StocksToTrade
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - FinancialContent
HeartBeam (BEAT) Stock News Today: FDA Clearance Ignites Rally, Analysts Lift Targets, and What Investors Are Watching Next (Dec. 17, 2025) - ts2.tech
HeartBeam Stock Surges 388%, With A 9-Day Winning Spree - Trefis
HeartBeam Earns FDA Clearance for 12-Lead Synthesis Software - Diagnostic and Interventional Cardiology
HeartBeam’s Stock Soars After FDA Clearance for Innovative ECG Technology - StocksToTrade
HeartBeam Stock Surges 273%, With A 8-Day Winning Spree - Trefis
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
HeartBeam Stock 7-Day Winning Spree: Stock Climbs 227% - Trefis
Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
HeartBeam Shares Skyrocket: FDA Boost - timothysykes.com
HeartBeam Soars with FDA Approval for Breakthrough ECG Technology - timothysykes.com
HeartBeam Stock Soars: Should You Buy? - timothysykes.com
symbol__ Stock Quote Price and Forecast - CNN
Heartbeam stock is a buy, this analyst says - Cantech Letter
HeartBeam Stock Surges 201%, With A 6-Day Winning Spree - Trefis
Benchmark Upgrades HeartBeam (BEAT) - Nasdaq
BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System - sharewise.com
HeartBeam updates regulatory strategy for 12-lead ECG Synthesis Software - MSN
HeartBeam Stock Surges: Analyzing the Uptrend - StocksToTrade
Why Is Micro Cap HeartBeam Stock Surging On Wednesday? - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
HeartBeam swells on turning FDA rejection into ECG clearance - Fierce Biotech
3 Penny Stocks to Watch Now, 12/11/25 - TipRanks
Why did BEAT stock rocket 72% in pre-market today? - MSN
HeartBeam receives US FDA clearance for at-home arrhythmia assessment with cable-free 12-lead ECG - Cardiac Rhythm News
HeartBeam (BEAT) Receives Upgrade from Benchmark Analyst | BEAT Stock News - GuruFocus
HeartBeam go-to-market strategy remains on track, says Benchmark - TipRanks
HeartBeam stock soars as H.C. Wainwright doubles price target on FDA clearance - Investing.com India
HeartBeam sinks after ‘Not Substantially Equivalent’ letter from FDA - MSN
HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views - ts2.tech
Most Active U.S. Stocks Today: HeartBeam, Nvidia, Tesla, Netflix and Nextdoor Lead Volatile Trade (Dec. 11, 2025) - ts2.tech
5-Day Rally Sends HeartBeam Stock Up 120% - Trefis
HeartBeam Receives FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal - citybuzz
HeartBeam announces FDA clearance for 12-lead ECG synthesis software - MSN
Oracle, Synopsys, Heartbeam, Planet Labs And Adobe: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
HC Wainwright & Co. Maintains HeartBeam (BEAT) Buy Recommendation - Nasdaq
Heartbeam wins appeal, gains FDA clearance - BioWorld MedTech
HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - NewMediaWire
FDA Greenlight Sends HeartBeam, Photronics, And Designer Brands Shares Climbing - Finimize
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - Digital Journal
HeartBeam’s Leap: Should Investors Be Wary? - StocksToTrade
FDA Clears HeartBeam Cable-free 12-lead ECG - respiratory-therapy.com
HeartBeam Secures FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal - citybuzz
HeartBeam (BEAT) Stock: Surges 50% After FDA Grants Clearance For its 12-lead ECG Device - parameter.io
HeartBeam (BEAT) Analyst Rating: HC Wainwright Raises Price Targ - GuruFocus
HeartBeam price target raised to $5.50 from $2.50 at H.C. Wainwright - TipRanks
FDA clears HeartBeam’s at-home arrhythmia assessment tool - Yahoo
Weekly Trades: Is HeartBeam Inc stock recession proofTrade Entry Report & Community Trade Idea Sharing Platform - BỘ NỘI VỤ
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):